Conference Description:

Conference Series LLC LTD invites you to the 15th International Conference and Exhibition on Metabolomics & Systems Biology during April 29-30, 2019, Kyoto Japan. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world-class Scientists.

Metabolomics Congress 2019 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more.

Conference is attracting academicians including Professors, PhD Scholars, Students, Pharmaceutical Industrial Giants, Toxicology Societies and the people Associated, Nobel laureates in Health Care and Medicine, Life science experts, Pharmaceutical companies, Clinical Laboratories and Technicians, Bioinformatics Professionals, Research Institutes and members, Supply Chain Companies, Manufacturing Companies, Training Institutes, Business Entrepreneurs.

Metabolomics congress 2019 will be underlined by the presence of academicians including metabolomics educators, postgraduates, affiliations, Industrial Giants, Business Entrepreneurs etc. This meeting comprises brief Keynote presentations, Speaker talks, Exhibition, Symposia, and Workshops.

The conference will be the perfect platform for:

Honorable scientific talks by the global scientific community
Sterling workshop sessions
Awards and Global Recognition to meritorious Researchers
Global Networking opportunities with 50+ Countries
Novel Techniques to Benefit Your Research
Exquisite Platform for showcasing your products and International Sponsorship
Poster - paper presentations and world-class exhibitions
Opportunities to gain a deeper understanding of the topic
Meet Academics and Industrial professionals to get inspired
Great credits for the work in progress
Valuable talks and symposiums from renowned speakers
Meaningful sessions and accomplishments

Sessions/Tracks

Biochemistry Conferences 2019 is delighted to welcome each one of the individuals to the "Metabolomics congress 2019" amidst April 29-April 30, 2019, at Kyoto, Japan which provide a forum for an exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field.

Metabolomics congress 2019 will be underlined by the presence of academicians including metabolomics educators, postgraduates, affiliations, Industrial Giants, Business Entrepreneurs etc. This meeting comprises brief Keynote presentations, Speaker talks, Exhibition, Symposia, and Workshops.

Theme: Metabolomics:Recent trends and future challenges

Track 1 : Cancer Therapeutic Approaches

Cancer biomarkers have many potential applications in cancer treatment, including screening, diagnosis, risk assessment, prediction of response to treatment, and monitoring of progression of disease. Metabolomics is growing in the field with particular attention to its application as a biomarker in cancer diagnosis. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, lipids, proteins, sugars, and little metabolites, nucleic acid, cytokinetic and cytogenetic parameters etc.

Track 2 : Metabolic Syndrome

Metabolic syndrome in short words can be explained as a group of conditions which includes increased blood pressure, abnormal cholesterol, high blood sugar, excess body fat around the waist, and or triglyceride levels — that occur together, increasing your risk of heart disease, diabetes and stroke. It is closely related to inactivity and overweight. Recent researches proved that prolonged chronic stress can be a cause for metabolic syndrome by disrupting the hormonal balance of the hypothalamic-pituitary-adrenal axis.

Track 3: Metabolomics in Precision Medicine

Precision medicine is rapidly developing tool for medical treatment to a small group or even individual patients based on their genetics, lifestyle and environment. It relies heavily on developments in systems biology and Metabolomics disciplines, including metabolomics. While a few advances in prescription have been made, the practice is not as of now being used for most diseases.

Track 4 : Frontiers of Metabolomics Research

Metabolomics studies can incite enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower use of computational approaches to manage the examination of disease and biomedical frames. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to enhance a more extensive cluster of little particle metabolites

Track 5 : Therapeutic Metabolomics

Metabolites has non-invading nature and close relation to the phenotype. That makes it a perfect tool for the pharmaceutical, agricultural industries and preventive healthcare among others. Therapeutic metabolomics studies are done by Centre for Metabolomics. Computational immunology is the branch of science that incorporates bioinformatics ways and high-throughput genomic to deal with immunology.

Track 6 : Transcriptomics & Metabolic pathways

Transcriptomic studies deals with the measurement of simultaneous expression of up to thousands of genes and can be used to identify which genes are down or up regulated under certain conditions. Metabolic pathway is a series of concoction responses occurring inside a cell. In a pathway metabolite, the beginning compound is changed by an arrangement of synthetic responses. These responses are catalyzed by enzymes. These chemicals frequently require dietary minerals, vitamins, and different cofactors to work. Metabolic pathways are classified as anabolic and catabolic pathways.

Track 7 : Metabolic Modelling

Metabolic modeling is done to have a deep insight into the molecular mechanisms of a particular organism. The metabolic pathways break down into their respective reactions and enzymes through reconstruction process and analyses them within the perspective of the entire network. A mathematical model is created by collecting all the relevant metabolic information of the organism. A deep analysis of these reconstructed pathways can allow identification of key features of metabolism such as robustness, gene essentiality, growth yield and resource distribution. This information can then be applied to create novel biotechnological methods.

Track 8 : Clinical Metabolomics & Lipidomics

Clinical metabolomics involves the application of clinical laboratory protocols, standards and oversight to a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.

Track 9 : Plant & Environmental Metabolomics

Metabolomics is the study of exogenous and endogenous low atomic mass metabolites inside of a cell, tissue, or bio fluid of a life form. Plant Metabolomics deals with evaluation of plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool of plants under particular conditions whereas environmental metabolomics is the utilization of strategies to find out the relation between life forms with their surroundings Using Metabolomics, a better understanding of the correlation between biochemical composition and genes of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function.

Track 10 : Food & Nutritional Metabolomics

Nutritional metabolomics is use chemical profiling of small molecule to support assimilation of nutrition and diet in complex biosystems research.Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics derived from the digestion and biotransformation of foods and their constituents in which MS techniques are considered indispensable.

Track 11: Metabolomic devices

Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomics research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex. Bruker, AB SCIEX, and Thermo Fisher likewise offer instruments for imaging MS, additionally called MALDI imaging.

Track 12 : Analytical Platforms in Metabolomics

Metabolomics is the subjective and quantitative investigation of small particles such as thiols, lipids, amino acids, nucleic acids, vitamins, peptides, natural acids and starches etc. The current advancement of diagnostic stages such as UPLC, GC, HPLC, CE coupled to MS and NMR spectroscopy empowers measurement, partition, portrayal, discovery and of these metabolites and other related metabolic pathways.

Track 13 : Data Analysis & Systems Biology

Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “metabolomics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.

Track 14 : Enhancing Analytical Approaches

The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology, drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Agilent Technologies, Thermo Scientific, Chenomx and Human metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.

Track 15 : Case Reports

Metabolites are key regulators of systems homeostasis. As such, changes in concentrations and fluxes of specific groups of metabolites may reflect systemic responses to environmental, lifestyle, and therapeutic challenges. Thus, case reports are inevitable factors in metabolite studies. Different case studies include heart disease, clinical studies, diabetes studies, cancer cases etc.

Track 16 : Proteomics in medicine

Molecular Medicine stimulates the reflective of the biological mechanism of disease at the cellular and molecular levels for enhanced treatment, prevention and diagnoses of disease. Proteomics plays a vital role in molecular medicine and medical research, such as in diagnostics and drug discovery, because of the connection between genes, proteins, and diseases. It is considered to be the next step in modern biology. Proteomics is dynamic compared to genomics because it changes constantly to reflect the cell’s environment. The main objectives in the area of proteomics are; identifying all proteins in different samples and analyze differential protein expression , characterize proteins by studying and identifying their function, recognize protein interaction network and cellular localization. Cancer biologists have made the first attempts to utilize proteomics for prognostic and diagnostic purposes. Recently developed serum-based proteomic pattern diagnostics, which is a new method of diagnosis and disease identification for ovarian cancer detection.

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship